Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action
暂无分享,去创建一个
[1] K. Abnous,et al. Antidepressant Effect of Crocus sativus Aqueous Extract and its Effect on CREB, BDNF, and VGF Transcript and Protein Levels in Rat Hippocampus , 2014, Drug Research.
[2] H. Hosseinzadeh,et al. Effect of Crocus sativus L. (Saffron) on Coagulation and Anticoagulation Systems in Healthy Volunteers , 2014, Phytotherapy research : PTR.
[3] V. Krajka-Kuźniak,et al. Hawthorn (Crataegus oxyacantha L.) Bark Extract Regulates Antioxidant Response Element (ARE)‐Mediated Enzyme Expression Via Nrf2 Pathway Activation in Normal Hepatocyte Cell Line , 2014, Phytotherapy research : PTR.
[4] S. Akhondzadeh,et al. A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients. , 2014, Journal of affective disorders.
[5] H. Hosseinzadeh,et al. Bioactivity assessment and toxicity of crocin: a comprehensive review. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[6] K. Abnous,et al. Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus , 2014, DARU Journal of Pharmaceutical Sciences.
[7] Garth L. Maker,et al. A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[8] S. Szanton,et al. Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies , 2014, Psychosomatic medicine.
[9] S. Anton,et al. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. , 2013, Journal of integrative medicine.
[10] H. Hosseinzadeh,et al. Crocetin attenuates spatial learning dysfunction and hippocampal injury in a model of vascular dementia. , 2013, Current neurovascular research.
[11] S. Newmaster,et al. DNA barcoding detects contamination and substitution in North American herbal products , 2013, BMC Medicine.
[12] Klaus P. Ebmeier,et al. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. , 2013, Journal of affective disorders.
[13] S. Samarghandian,et al. Safranal treatment improves hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats. , 2013, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[14] Khalil Abnous,et al. Protective effect of crocin on diazinon induced cardiotoxicity in rats in subchronic exposure. , 2013, Chemico-biological interactions.
[15] H. Hosseinzadeh,et al. Avicenna's (Ibn Sina) the Canon of Medicine and Saffron (Crocus sativus): A Review , 2013, Phytotherapy research : PTR.
[16] S. Salton,et al. The role of neurotrophins in major depressive disorder , 2013, Translational neuroscience.
[17] S. Samarghandian,et al. Safranal ameliorates antioxidant enzymes and suppresses lipid peroxidation and nitric oxide formation in aged male rat liver , 2013, Biogerontology.
[18] K. Abu-Salah,et al. Determination of total xanthones in Garcinia mangostana fruit rind extracts by ultraviolet (UV) spectrophotometry , 2013 .
[19] H. Hosseinzadeh,et al. Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers , 2013, Iranian journal of basic medical sciences.
[20] H. Sadeghnia,et al. Protective Effect of Safranal, a Constituent of Crocus sativus, on Quinolinic Acid-induced Oxidative Damage in Rat Hippocampus , 2013, Iranian journal of basic medical sciences.
[21] S. Akhondzadeh,et al. Saffron for treatment of fluoxetine‐induced sexual dysfunction in women: randomized double‐blind placebo‐controlled study , 2013, Human psychopharmacology.
[22] Takuji Tanaka,et al. Dietary Crocin Inhibits Colitis and Colitis-Associated Colorectal Carcinogenesis in Male ICR Mice , 2012, Evidence-based complementary and alternative medicine : eCAM.
[23] K. Rangappa,et al. A dietary colorant crocin mitigates arthritis and associated secondary complications by modulating cartilage deteriorating enzymes, inflammatory mediators and antioxidant status. , 2012, Biochimie.
[24] P. Tarantilis,et al. Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive–compulsive disorder , 2012, Neuroscience Letters.
[25] A. Baker,et al. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity , 2012, Brain, Behavior, and Immunity.
[26] Hesham A El-Beshbishy,et al. Crocin "saffron" protects against beryllium chloride toxicity in rats through diminution of oxidative stress and enhancing gene expression of antioxidant enzymes. , 2012, Ecotoxicology and environmental safety.
[27] R. Ho,et al. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. , 2012, Journal of affective disorders.
[28] S. Bisti,et al. A Longitudinal Follow-Up Study of Saffron Supplementation in Early Age-Related Macular Degeneration: Sustained Benefits to Central Retinal Function , 2012, Evidence-based complementary and alternative medicine : eCAM.
[29] Lina Yang,et al. Protective Effect of Crocetin on Hemorrhagic Shock–Induced Acute Renal Failure in Rats , 2012, Shock.
[30] G. Fontecchio,et al. Anti-inflammatory properties of drugs from saffron crocus. , 2012, Anti-inflammatory & anti-allergy agents in medicinal chemistry.
[31] S. Akhondzadeh,et al. Effect of saffron on fluoxetine-induced sexual impairment in men: randomized double-blind placebo-controlled trial , 2012, Psychopharmacology.
[32] M. Maes,et al. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.
[33] M. Berk,et al. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors , 2012, Inflammopharmacology.
[34] M. Kubera,et al. Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[35] H. Sahraei,et al. Saffron (Crocus sativus) Aqueous Extract and its Constituent Crocin Reduces Stress‐induced Anorexia in Mice , 2011, Phytotherapy research : PTR.
[36] A. Scholey,et al. Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence , 2011, European Neuropsychopharmacology.
[37] A. Bandegi,et al. Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning and memory deficits induced by chronic stress in rats. , 2011, European journal of pharmacology.
[38] Andrew H. Miller,et al. Is Depression an Inflammatory Disorder? , 2011, Current psychiatry reports.
[39] Askary Vahid Reza,et al. Saffron chemicals and medicine usage , 2011 .
[40] H. Sahraei,et al. Reduction of metabolic and behavioral signs of acute stress in male Wistar rats by saffron water extract and its constituent safranal , 2011, Pharmaceutical biology.
[41] M. Bloch,et al. The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis , 2011, Neuropsychopharmacology.
[42] A. Simmons,et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.
[43] R. Komaki,et al. Psychological and neuroendocrinological effects of odor of saffron (Crocus sativus). , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[44] M. Berk,et al. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[45] C. Pariante,et al. Glucocorticoids, cytokines and brain abnormalities in depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[46] I. Lucki,et al. The role of serotonin receptor subtypes in treating depression: a review of animal studies , 2011, Psychopharmacology.
[47] Ji-Ho Park,et al. Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. , 2010, European journal of pharmacology.
[48] S. Bisti,et al. Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.
[49] Yong-Ku Kim,et al. The Roles of BDNF in the Pathophysiology of Major Depression and in Antidepressant Treatment , 2010, Psychiatry investigation.
[50] Massimo F. Marcone,et al. Chemical and biological properties of the world's most expensive spice: Saffron , 2010 .
[51] H. Hosseinzadeh,et al. Sub-acute effects of diazinon on biochemical indices and specific biomarkers in rats: protective effects of crocin and safranal. , 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[52] S. Akhondzadeh,et al. Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16‐week, randomized and placebo‐controlled trial , 2010, Journal of clinical pharmacy and therapeutics.
[53] Bikram Singh,et al. Selective Th2 Upregulation by Crocus sativus: A Neutraceutical Spice , 2010, Evidence-based complementary and alternative medicine : eCAM.
[54] S. M. Asdaq,et al. Potential of Crocus sativus (saffron) and its Constituent, Crocin, as Hypolipidemic and Antioxidant in Rats , 2010, Applied biochemistry and biotechnology.
[55] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials , 2010, Obstetrics and gynecology.
[56] N. Herrmann,et al. A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.
[57] N. Alenina,et al. Tryptophan Hydroxylase as Novel Target for the Treatment of Depressive Disorders , 2010, Pharmacology.
[58] R. Duman. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression , 2009, Dialogues in clinical neuroscience.
[59] G. Ao,et al. Preventive effect of crocin in inflamed animals and in LPS-challenged RAW 264.7 cells. , 2009, Journal of agricultural and food chemistry.
[60] M. Dimatteo,et al. A Meta-Analysis , 2009 .
[61] J. Suls,et al. Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis , 2009, Psychosomatic medicine.
[62] H. Hosseinzadeh,et al. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[63] R. Duman,et al. Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.
[64] Stafford L. Lightman,et al. The HPA axis in major depression: classical theories and new developments , 2008, Trends in Neurosciences.
[65] Rezazadeh Sh.A.,et al. Petal and Stigma of Crocus sativus L. in the Treatment of Depression: A Pilot Double - blind Randomized Trial , 2008 .
[66] S. Akhondzadeh,et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double‐blind, randomised and placebo‐controlled trial , 2008, BJOG : an international journal of obstetrics and gynaecology.
[67] J. Russell,et al. Neurobiology of depression: an integrated view of key findings , 2007, International journal of clinical practice.
[68] S. Akhondzadeh,et al. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[69] Andrew H. Miller,et al. Cytokine-effects on glucocorticoid receptor function: Relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression , 2007, Brain, Behavior, and Immunity.
[70] S. Akhondzadeh,et al. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[71] R. Duman,et al. A Neurotrophic Model for Stress-Related Mood Disorders , 2006, Biological Psychiatry.
[72] X. Shen,et al. Effects of crocetin on antioxidant enzymatic activities in cardiac hypertrophy induced by norepinephrine in rats. , 2006, Die Pharmazie.
[73] M. Ansari,et al. Neuroprotection by crocetin in a hemi-parkinsonian rat model , 2005, Pharmacology Biochemistry and Behavior.
[74] D. Nutt,et al. Acute Tryptophan Depletion. Part I: Rationale and Methodology , 2005, The Australian and New Zealand journal of psychiatry.
[75] S. Akhondzadeh,et al. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. , 2005, Journal of ethnopharmacology.
[76] D. Kennedy,et al. The psychopharmacology of herbal extracts: issues and challenges , 2005, Psychopharmacology.
[77] S. Akhondzadeh,et al. Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial , 2004, Phytotherapy research : PTR.
[78] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[79] R. Salomon,et al. Acute tryptophan depletion: a method of studying antidepressant action. , 1992, The Journal of clinical psychiatry.
[80] M. Maes,et al. Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications , 2013, CNS Drugs.
[81] S. Saeidnia,et al. An overview on saffron, phytochemicals, and medicinal properties , 2013, Pharmacognosy reviews.
[82] J. Benjamin,et al. The biology of tryptophan depletion and mood disorders. , 2010, The Israel journal of psychiatry and related sciences.
[83] C. Zheng,et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. , 2009, Journal of Natural Medicines.
[84] S. Akhondzadeh,et al. A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease , 2009, Psychopharmacology.
[85] A. Hensel,et al. Saffron in phytotherapy: Pharmacology and clinical uses , 2007, Wiener Medizinische Wochenschrift.
[86] Hossein Hosseinzadeh,et al. ANTIDEPRESSANT EFFECT OF KAEMPFEROL, A CONSTITUENT OF SAFFRON (CROCUS SATIVUS) PETAL, IN MICE AND RATS , 2007 .
[87] Andrew H. Miller,et al. Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.
[88] S. Akhondzadeh,et al. Bmc Complementary and Alternative Medicine Comparison of Crocus Sativus L. and Imipramine in the Treatment of Mild to Moderate Depression: a Pilot Double-blind Randomized Trial [isrctn45683816] , 2004 .
[89] G. Eisenbrand,et al. Crocus sativus L. , 1992 .
[90] P. Cowen,et al. A role for 5-HT in the action of antidepressant drugs. , 1990, Pharmacology & therapeutics.
[91] Y. S. Lewis,et al. Saffron (Crocus Sativus Linn.) — Cultivation, processing, chemistry and standardization , 1984 .
[92] R. D. Crecchio. The saffron crocus. , 1960 .